- Home
- VIGL vs DTC Comparison
VIGL vs DTC Comparison
Compare VIGL & DTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIGL
- DTC
- Stock Information
- Founded
- VIGL 2020
- DTC 2011
- Country
- VIGL United States
- DTC United States
- Employees
- VIGL N/A
- DTC N/A
- Industry
- VIGL Biotechnology: Pharmaceutical Preparations
- DTC Recreational Games/Products/Toys
- Sector
- VIGL Health Care
- DTC Consumer Discretionary
- Exchange
- VIGL Nasdaq
- DTC Nasdaq
- Market Cap
- VIGL 95.2M
- DTC 76.7M
- IPO Year
- VIGL 2022
- DTC 2021
- Fundamental
- Price
- VIGL $2.08
- DTC $1.07
- Analyst Decision
- VIGL Strong Buy
- DTC Hold
- Analyst Count
- VIGL 5
- DTC 6
- Target Price
- VIGL $19.75
- DTC $2.52
- AVG Volume (30 Days)
- VIGL 331.7K
- DTC 268.2K
- Earning Date
- VIGL 11-07-2024
- DTC 03-13-2025
- Dividend Yield
- VIGL N/A
- DTC N/A
- EPS Growth
- VIGL N/A
- DTC N/A
- EPS
- VIGL N/A
- DTC N/A
- Revenue
- VIGL N/A
- DTC $476,331,000.00
- Revenue This Year
- VIGL N/A
- DTC N/A
- Revenue Next Year
- VIGL N/A
- DTC $1.51
- P/E Ratio
- VIGL N/A
- DTC N/A
- Revenue Growth
- VIGL N/A
- DTC N/A
- 52 Week Low
- VIGL $1.49
- DTC $1.03
- 52 Week High
- VIGL $6.06
- DTC $3.05
- Technical
- Relative Strength Index (RSI)
- VIGL 55.12
- DTC 42.57
- Support Level
- VIGL $1.79
- DTC $1.03
- Resistance Level
- VIGL $2.02
- DTC $1.20
- Average True Range (ATR)
- VIGL 0.16
- DTC 0.06
- MACD
- VIGL 0.08
- DTC -0.00
- Stochastic Oscillator
- VIGL 96.72
- DTC 20.00
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.
About DTC Solo Brands Inc.
Solo Brands Inc is a Direct-To-Consumer (DTC) platform. It operates four premium outdoor lifestyle brands Solo Stove, Oru, ISLE, TerraFlame, IcyBreeze, and Chubbies apparel. Solo Stove offers portable, low-smoke fire pits, grills, and camping stoves for backyard and outdoor use in different sizes, fire pit bundles, gear kits, stoves, cookware, dinnerware, and a variety of clothing and accessories. Oru offers a flagship line of lightweight, foldable kayaks. ISLE produces high-quality stand-up paddle boards with colorful designs that are engineered to accommodate every skill level, style, and interest. Chubbies is a fun-loving, premium apparel brand that offers well-fitted comfortable clothing, and other brands with different services and products.